Guidelines for clinical application of mifepristone

Title: Guidelines for clinical application of mifepristone
Edition: Original
Classification: Standard guideline
Field: Others
Countries and regions: China
Guidelines users: Clinicians, pharmacists, nurses and other stakeholders.
Evidence classification method: The guideline will use the Grades of Recommendations Assessment, Development and Evaluation (GRADE) to rate the quality of evidence and to grade the strength of recommendations.
Development unit: China Medical Education Association, Beijing Association of Holistic Integrative Medicine.
Registration time: 2023-11-17
Registration number: PREPARE-2023CN916
Purpose of the guideline: A lot of medication risks related to mifepristone therapy still remain to be identified and standardized. This project aims to establish an evidenced-based practice guidelines for clinical application of mifepristone.